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Abstract 
Background: Clinical complications associated with atherosclerotic plaques arise from luminal obstruction due to 
plaque growth or destabilization leading to rupture. We previously demonstrated that overexpression of insulin recep‑
tor isoform A (IRA) and insulin‑like growth factor‑I receptor (IGF‑IR) confers a proliferative and migratory advantage 
to vascular smooth muscle cells (VSMCs) promoting plaque growth in early stages of atherosclerosis. However, the 
role of insulin receptor (IR) isoforms, IGF‑IR or insulin‑like growth factor‑II receptor (IGF‑IIR) in VSMCs apoptosis during 
advanced atherosclerosis remains unclear.
Methods: We evaluated IR isoforms expression in human carotid atherosclerotic plaques by consecutive immuno‑
precipitations of insulin receptor isoform B (IRB) and IRA. Western blot analysis was performed to measure IGF‑IR, IGF‑
IIR, and α‑smooth muscle actin (α‑SMA) expression in human plaques. The expression of those proteins, as well as the 
presence of apoptotic cells, was analyzed by immunohistochemistry in experimental atherosclerosis using BATIRKO; 
 ApoE−/− mice, a model showing more aggravated vascular damage than  ApoE−/− mice. Finally, apoptosis of VSMCs 
bearing IR  (IRLoxP+/+ VSMCs), or not  (IR−/− VSMCs), expressing IRA (IRA VSMCs) or expressing IRB (IRB VSMCs), was 
assessed by Western blot against cleaved caspase 3.
Results: We observed a significant decrease of IRA/IRB ratio in human complicated plaques as compared to non‑
complicated regions. Moreover, complicated plaques showed a reduced IGF‑IR expression, an increased IGF‑IIR 
expression, and lower levels of α‑SMA indicating a loss of VSMCs. In experimental atherosclerosis, we found a signifi‑
cant decrease of IRA with an increased IRB expression in aorta from 24‑week‑old BATIRKO;  ApoE−/− mice. Further‑
more, atherosclerotic plaques from BATIRKO;  ApoE−/− mice had less VSMCs content and higher number of apoptotic 
cells. In vitro experiments showed that IGF‑IR inhibition by picropodophyllin induced apoptosis in VSMCs. Apoptosis 
induced by thapsigargin was lower in  IR−/− VSMCs expressing higher IGF‑IR levels as compared to  IRLoxP+/+ VSMCs. 
Finally, IRB VSMCs are more prone to thapsigargin‑induced apoptosis than IRA or  IRLoxP+/+ VSMCs.
Conclusions: In advanced human atherosclerosis, a reduction of IRA/IRB ratio, decreased IGF‑IR expression, or 
increased IGF‑IIR may contribute to VSMCs apoptosis, promoting plaque instability and increasing the risk of plaque 
rupture and its clinical consequences.
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Background
Atherosclerosis is a chronic disease affecting large arter-
ies that involves the formation of plaques containing 
vascular and inflammatory cells, lipids and extracellular 
matrix [1]. Its clinical complications arise from luminal 
obstruction due to plaque growth leading to vessel ste-
nosis, and/or formation of unstable plaques that acutely 
rupture leading to an occlusive thrombus formation [2]. 
Vascular smooth muscle cells (VSMCs) play a main role 
in this process as they contribute to plaque growth in 
early stages, but favor plaque stability in advanced stages 
of atherogenesis [3].
The insulin and insulin-like growth factors (IGFs) sign-
aling is mediated by hormone interaction with the insulin 
receptor (IR) and the IGF-I receptor (IGF-IR), which are 
members of subclass II tyrosine kinase receptor super-
family [4, 5]. In mammals, alternative splicing of the IR 
gene gives rise to two isoforms: IRA and IRB [6]. Indeed, 
IRB has an additional 12-amino acid sequence encoded 
by the exon 11. Although both isoforms have similar 
affinity for insulin, IRA exhibits a higher affinity for IGFs, 
especially for IGF-II [7]. Thus, IRB is preferentially asso-
ciated with metabolic and differentiating signals, whereas 
IRA mainly favors cell growth, proliferation and survival 
[8]. In addition to IR and IGF-IR, IGF-II binds IGF-II 
receptor (IGF-IIR) with high affinity. IGF-IIR is a type I 
transmembrane glycoprotein that also have high affinity 
for mannose-6-phosphate, and can therefore bind lyso-
somal enzymes and other growth factors and cytokines 
[9]. It plays a well-documented role in the intracellu-
lar transport of lysosomal enzymes and in clearance of 
IGF-II from the circulation. However, although IGF-IIR 
contains neither tyrosine kinase activity nor an autophos-
phorylation site, it does link to G-proteins providing a 
mechanism for signal transduction that may be involved 
in cell behavior regulation [10, 11].
In early atherosclerotic lesions, IGFs contribute to 
plaque growth by promoting VSMCs proliferation and 
migration [12]. In this regard, we previously demon-
strated that overexpression of IGF-IR or IRA isoform 
during early atherosclerosis confers a proliferative and 
migratory advantage to VSMCs favoring atherosclerotic 
progression [13, 14]. In advanced stages, the imbalance 
between cell death and survival may substantially affect 
the cellularity and integrity of atherosclerotic lesions con-
tributing to plaque instability. Unstable plaques that are 
prone to rupture have a thin fibrous cap with a decreased 
number of VSMCs and a dense infiltration of inflam-
matory cells [15, 16], as well as an increased apoptosis 
of VSMCs and macrophages [17]. IGF-I, through IGF-
IR, has been reported to prevent atherosclerotic plaque 
instability by its mitogenic and antiapoptotic effects on 
VSMCs [18–20]. However, the role of IR isoforms or 
IGF-IIR in VSMCs apoptosis and thereby in plaque insta-
bility remains unknown. In the present study, we ana-
lyzed the expression of IR isoforms, IGF-IR and IGF-IIR, 
as well as VSMCs content in human carotid atheroscle-
rotic plaques and in experimental models of atheroscle-
rosis. Finally, we assessed the contribution of IR isoforms 
and IGF-IR to the apoptosis of murine aortic VSMCs 
lines.
Methods
Patients
Ten atherosclerotic plaques from patients undergoing 
carotid endarterectomy at IIS-Fundación Jiménez Díaz 
(Table  1) were dissected separating the stenosing com-
plicated plaque (CP) from the non-complicated (NCP) 
fibrous adjacent area. The CP was defined as the lesion, 
usually localized at the origin of the internal carotid 
artery responsible for the surgery. The CP contained an 
important proportion of inflammatory cells (Stary stages 
V–VI), whereas the NCP adjacent areas were mainly 
composed of VSMCs and lipid deposits (Stary stage III). 
Masson’s trichrome stain of representative NCP and CP 
samples are shown. The study was approved by the hospi-
tal’s ethics committee (IIS-Fundación Jiménez Díaz) with 
the reference number (PI1442016) according to the insti-
tutional and the Good Clinical Practice guidelines, which 
was performed in accordance with the Declaration of 
Helsinki. All participants gave written informed consent.
Experimental models
Male mice were maintained on a 12-h light–dark cycle 
and 23 °C room temperature. All animals used are under 
C57BL/6 genetic background [21]. Generation of brown 
adipose tissue-specific insulin receptor knockout (BAT-
IRKO);  ApoE−/− mice by crossing female  ApoE−/− mice 
with male BATIRKO mice was previously described 
[21]. Six week-old male Control mice,  ApoE−/− mice 
and BATIRKO;  ApoE−/− mice were fed on a standard 
diet (3% kcal from fat) for 62  weeks or a Western type 
diet (21%  kcal from fat) for 18  weeks, and sacrificed at 
24 weeks or 15 months of age, respectively. Anesthetized 
Table 1 Clinical characteristics of patients bearing carotid 
atherosclerosis
Variable Patients (n = 10)
Age, years 69 (57–78)
Gender (male/female), % 100/0
Diabetes mellitus, % 50
Hypertension, % 60
Dyslipidemia, % 50
Coronary artery disease, % 30
Current smoking, % 50
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mice (Avertin, 250 mg/kg, ip) were saline-perfused. The 
aortic root was embedded in Tissue-Tek® optimum cut-
ting temperature (OCT) Compound and frozen for his-
tological analysis, and the thoracic aorta was frozen for 
RNA extraction. All animal experimentation described in 
this manuscript was conducted according with accepted 
standards of human animal care, as approved by the 
institutional committee of Complutense University of 
Madrid (reference number: ES280790000086). All animal 
procedures have been performed according to the guide-
lines from Directive 2010/63/EU of the European Parlia-
ment and the National Institutes of Health (NIH) on the 
protection of animals used for scientific purposes.
Cell cultures
Generation of immortalized  IRLoxP+/+,  IR−/−, IRA and 
IRB VSMCs lines was previously described [13]. Briefly, 
primary VSMCs were obtained from thoracic aorta arter-
ies of 3 male 8-week-old  IRLoxP+/+ mice. Anesthetized 
mice (Avertin, 250  mg/kg, ip) were saline perfused and 
thoracic aorta arteries were submitted to collagenase 
dispersion and primary culture. Then, primary culture 
of  IRLoxP+/+ VSMCs were immortalized by transfection 
with pBabe retroviral vector encoding SV40 Large T anti-
gen and selected with 1  μg/mL puromycin for 3  weeks. 
Immortalized  IRLoxP+/+ VSMCs were infected with 
adenoviruses encoding Cre recombinase to obtain  IR−/− 
VSMCs. Finally,  IR−/− VSMCs were transfected with 
pBABE retroviral vector encoding the individual spliced 
isoforms of the human IR, IRA or IRB, and selected with 
200 μg/mL hygromycin for 2 weeks to obtain IRA or IRB 
VSMCs respectively.
Cell lines were cultured to subconfluence (70–80%) 
with 10% foetal bovine serum (FBS)-DMEM for in vitro 
experiments. Cells were serum and glucose starved for 
4–5  h and then treated with IGF-I (10  nmol/L, Merck 
Millipore), IGF-II (10  nmol/L, Merck Millipore), the 
IGF-IR inhibitor picropodophyllin (1  µmol/L, PPP, 
Merck Millipore), and/or thapsigargin (0.1–100 nmol/L, 
Sigma-Aldrich).
Histological analysis
Paraffin-embedded human carotid atherosclerotic 
plaques were cross sectioned into 4  µm thick pieces, 
dewaxed, and rehydrated. Masson trichrome were per-
formed following manufacturer’s instructions and as pre-
viously described [22].
Aortic roots from experimental models were OCT-
embedded and sections of 7  μm interval were used for 
immunohistochemical studies. IR, IGF-IR, IGF-IIR 
and cleaved poly ADP ribose polymerase (PARP) were 
detected by immunoperoxidase with rabbit anti-IRβ (sc-
711), anti-IGF-IRβ (sc-713) and anti-IGF-IIR (sc-25462) 
polyclonal antibodies and anti-Cleaved PARP (ab32064) 
monoclonal antibody. We also performed immuno-
fluorescence against α-SMA using anti-actin, α-smooth 
muscle-Cy3™ mouse monoclonal antibody (C6198, 
Sigma-Aldrich) followed by 4′,6-diamidino-2-phenylin-
dole (DAPI) staining to localize nuclei.
Western blot analysis
Western blot analyses were performed on protein 
extracts from human plaques and from in  vitro experi-
ments as previously described [22]. The antibodies used 
were anti-IRβ, IGF-IRβ and IGF-IIR from Santa Cruz 
Biotechnology (Dallas, TX, USA); IRS-1 from Millipore 
(Billerica, MA, USA); p-IRS-1 (Ser307), p-AKT (Thr308), 
p-p42/44 MAPK (Thr202/Tyr204) and Cleaved Cas-
pase-3 (Asp175) from Cell Signaling Technology (Dan-
vers, MA, USA); anti-β-actin, α-SMA and α-tubulin from 
Sigma-Aldrich Corp. (St. Louis, MO, USA).
Immunoprecipitation
An amount of 150  µg protein from human plaques was 
immunoprecipitated at 4  °C with IRB isoform antibody 
(provided by Dr. Sesti and Dr. Hribal). Supernatants were 
subsequently immunoprecipitated with IRβ antibody 
recognizing both IR isoforms. Thus, immune complexes 
from first (only IRB isoform) or second (only IRA iso-
form) immunoprecipitations were collected on protein 
A-agarose beads and submitted to SDS-PAGE. Finally, 
immunoblots were incubated with anti-IRB or anti-IRβ 
antibodies to analyze the expression of IRB and IRA, 
respectively. To study the association between IR iso-
forms and IGF-IR or insulin receptor substrate 1 (IRS-1), 
immunoblots were reincubated with anti-IGF-Iβ, IRS-1 
or p-IRS (Ser307) antibodies.
RNA extraction and real‑time quantitative polymerase 
chain reaction
Total RNA was isolated from aorta of experimental mod-
els using TRIzol reagent (Invitrogen, Carlsbad, CA) and 
quantified by absorbance at 260 nm. One microgram of 
RNA was used to perform the reverse transcription with 
a High Capacity cDNA Archive kit (Applied Biosystems, 
Foster City, CA). Real-time quantitative PCR (qRT-PCR) 
was performed on an ABI Prism 7900 sequence detec-
tion PCR system (Applied Biosystems) according to the 
manufacturer’s protocol, using the ΔΔCt method as pre-
viously described [23]. Thus, the amount of target, nor-
malized to endogenous gene and relative to the control, 
is given by real-time quantitative (RQ)  =  2−ΔΔCt; ΔCt 
(cycle threshold)  =  Ct (target gene)  −  Ct (GAPDH); 
ΔΔCt  =  ΔCt for any sample  −  ΔCt for the control. 
Amplification of GAPDH was used in the same reaction 
of all samples as an internal control.
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Annexin V‑FITC and propidium iodide assays
106 cells were seeded in 60 mm-plates and the following 
day they were FBS deprived for 4 h and stimulated with 
IGF-I, IGF-II or PPP 1  h-previous to stimulation with 
thapsigargin for 18 h. After that, cells were counted and 
collected to perform apoptosis studies with Annexin 
V-FITC kit. Apoptotic cells are positively stained for 
Annexin V-FITC that binds to phosphatidylserine (PS) 
residues, but are negatively stained for propidium iodide 
(PI). Dead cells are positive for both, Annexin V-FITC 
and PI staining, whereas viable cells are negative for both 
Annexin V-FITC and PI. Finally, necrotic cells are posi-
tively stained for PI and negatively for Annexin V-FITC. 
For these experiments, a FACScalibur flow cytometer 
and Cell Quest Pro software (Becton–Dickinson) was 
used.
Statistical analysis
All values are expressed as mean  ±  standard error of 
the mean (SEM). Differences between two groups were 
assessed using paired two-tailed t-tests for human sam-
ples and unpaired two-tailed t-tests for experimental 
models and in  vitro experiments. Data involving more 
than two groups were analyzed using a one-way ANOVA 
followed by a Bonferroni test if differences were noted 
(GraphPad Prism 6.0). The null hypothesis was rejected 
when p < 0.05.
Results
Decrease of IRA/IRB ratio and IGF‑IR, increase of IGF‑IIR, 
and loss of VSMCs in complicated human atherosclerotic 
plaques
To assess the role of IR isoforms, IGF-IR and IGF-IIR in 
human advanced atherosclerosis, we used atheroscle-
rotic plaques from patients undergoing carotid endar-
terectomy. Ten carotid endarterectomy samples were 
carefully dissected separating the stenosing complicated 
plaque (CP, Stary stages V–VI) from the non-complicated 
(NCP, Stary stages III) fibrous adjacent area. Histological 
analysis revealed that complicated plaques contained an 
intraplaque hemorrhage and/or a certain degree of calci-
fication with a relatively important proportion of inflam-
matory cells. The adjacent non-complicated regions were 
composed of fibrous thickening with a variable content of 
VSMCs (Additional file 1: Figure S1).
Firstly, the expression of each IR isoform and its asso-
ciation with IGF-IR or IRS-1 were comparatively ana-
lyzed in complicated and non-complicated regions of 
human plaques by consecutive immunoprecipitations of 
IRB and IRA isoforms (Fig. 1). We observed a significant 
decrease of IRA expression, together with an increase 
of IRB, in complicated regions  (Fig.  1b). We also found 
that the expression of IRA/IGF-IR hybrid receptors was 
significantly higher in complicated regions of plaques 
(Fig.  1c). Regarding IRS-1 association with IRA or IRB, 
no significant differences were found in complicated as 
compared to non-complicated regions of the plaques 
(Fig. 1d).
Nevertheless, IRA or IRB-associated IRS-1 showed an 
increased inhibitory Ser307 phosphorylation in com-
plicated regions compared to non-complicated regions 
of plaques (Fig. 1e). Moreover, we observed a decreased 
insulin signaling in terms of Akt and p42/44 MAPK 
phosphorylation in complicated regions vs. non-com-
plicated regions of atherosclerotic plaques (Additional 
file  2: Figure S2). To evaluate the expression of IGF-IR, 
we used the supernatants of the second immunoprecipi-
tation in which this receptor would be as homodimers, 
since IR-associated IGF-IR was previously immunopre-
cipitated (Fig. 2a). We observed a reduced IGF-IR expres-
sion in complicated regions of the plaques. Conversely, 
the expression of IGF-IIR was significantly increased in 
complicated as compared to non-complicated regions of 
plaques (Fig. 2a).
In advanced atherosclerotic plaques, a loss of VSMCs 
as a result of their increased apoptosis may be key in 
plaque instability that seriously increases the risk of rup-
ture. We therefore analyzed the content of VSMCs in 
human atherosclerotic plaques. Western blot analysis of 
α-smooth muscle actin (α-SMA), a well-known marker 
of smooth muscle cells, showed a significant reduction 
of VSMCs number in complicated as compared to non-
complicated regions of plaques (Fig. 2b).
Decrease of IRA/IRB ratio and less VSMCs content 
in experimental atherosclerotic models
We wondered whether the findings obtained from human 
atherosclerotic plaques could also occur in experimental 
models of atherosclerosis. For this purpose, 24-week-old 
BATIRKO;  ApoE−/− mice under a Western type diet were 
used to develop more advanced atherosclerotic lesions 
as compared to Control and  ApoE−/− mice. These mice 
showed higher vascular damage, characterized by a sig-
nificant increase of stenosis, lesion area, lipid content and 
macrophage infiltration in aortic roots, than 24-week-
old  ApoE−/− mice [21]. In a second approach, Control, 
 ApoE−/− and BATIRKO;  ApoE−/− mice were fed on a 
standard diet and sacrificed at 15 months of age. Protein 
levels of IR in total area of aortic roots were very similar 
among the three groups of animals from the two experi-
mental models (Fig. 3a and Additional file 3: Figure S3A). 
However, the receptor was significantly diminished in 
the media of aortic roots from  ApoE−/− and BATIRKO; 
 ApoE−/− mice in both 24-week-old and 15-month-old 
models. We observed by qRT-PCR that mRNA expres-
sion of IRA isoform was significantly decreased, whereas 
Page 5 of 14Beneit et al. Cardiovasc Diabetol  (2018) 17:31 
IRB was increased in aorta from 24-week-old BATIRKO; 
 ApoE−/− mice (Fig.  3b). These data are consistent with 
the reduced IRA/IRB ratio found in complicated human 
plaques (Fig. 1b). A significant increase of IGF-IR protein 
was observed in aortic roots from both 24-week-old and 
15  month-old BATIRKO;  ApoE−/− mice in relation to 
their respective  ApoE−/− groups (Fig. 3c and Additional 
file  3: Figure S3B). Consistently, IGF-IR mRNA expres-
sion was significantly higher in aorta from 24-week-old 
BATIRKO;  ApoE−/− mice (Fig.  3d). IGF-IIR expression 
showed an increasing trend, although not significant, in 
aortic roots from 24-week-old mice BATIRKO;  ApoE−/− 
mice (Fig. 3e).
To study the VSMCs content in the atherosclerotic 
lesions of experimental models, we analyzed by immu-
nohistochemistry the α-SMA expression in aortic roots 
from the different groups of animals. A very significant 
reduction of α-SMA was found in 24-week-old BAT-
IRKO;  ApoE−/− mice as compared to the respective 
Control and  ApoE−/− groups (Fig. 4a). Moreover, athero-
sclerotic plaques from 15 month-old BATIRKO;  ApoE−/− 
mice also contained a significantly lower number of 
Fig. 1 IR isoforms expression and association with IGF‑IR or IRS‑1 in human carotid atherosclerotic plaques. Representative gels (a) and quantifica‑
tions (b–e) of IRA (left panels) and IRB (right panels) protein levels and their association with IGF‑IR, IRS‑1 or p‑IRS‑1 (Ser307) in non‑complicated 
regions (n = 10) and their respective complicated plaques (n = 10). 150 µg of protein from each human plaque were immunoprecipitated with IRB 
isoform antibody. Supernatants were subsequently immunoprecipitated with IRβ (IRA and IRB isoforms) antibody. Immune complexes from first 
(only IRB) or second (only IRA) immunoprecipitations were collected on protein A‑agarose beads and submitted to SDS‑PAGE.  IRLoxP+/+ VSMCs 
expressing both IR isoforms were used as an immunoprecipitation control. *p < 0.05, **p < 0.005 vs. NCP. CP complicated region of atherosclerotic 
plaque, IP immunoprecipitation, NCP non‑complicated region
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VSMCs than 15  month-old Control mice (Additional 
file  4: Figure S4A). An increased apoptosis is the major 
cause for the loss of VSMCs during atherogenesis [17]. 
We therefore evaluated the presence of apoptotic cells 
in aortic roots by immunostaining of the apoptosis 
marker cleaved poly ADP ribose polymerase (PARP). The 
amount of cleaved  PARP+ cells was markedly increased 
in aortic roots from both 24-week-old  ApoE−/− and 
BATIRKO;ApoE−/− mice in relation to 24-week-old Con-
trol mice (Fig. 4b). Similarly, aortic roots from 15 month-
old  ApoE−/− and BATIRKO;  ApoE−/− mice had higher 
number of apoptotic cells than 15  month-old Control 
mice. In addition, the presence of apoptotic cells was 
significantly higher in 15 month-old BATIRKO;  ApoE−/− 
mice as compared to  ApoE−/− group (Additional file  4: 
Figure S4B).
Antiapoptotic effect of IGF‑IR on VSMCs
To assess the role of IR isoforms and IGF-IR in VSMCs 
apoptosis, four murine aortic VSMCs lines were used: 
bearing IR  (IRLoxP+/+ VSMCs), lacking IR  (IR−/− 
VSMCs), expressing IRA isoform (IRA VSMCs) or 
alternatively expressing IRB isoform (IRB VSMCs). We 
previously demonstrated that IGF-IR is a main contribu-
tor to VSMC migration during early stages of atheroscle-
rosis [14]. In the current work, we hypothesized that a 
decreased expression or activation of IGF-IR might pro-
mote apoptosis of VSMCs. To assure this,  IRLoxP+/+ and 
 IR−/− VSMCs were treated with the highly specific inhib-
itor of IGF-IR tyrosine phosphorylation picropodophyllin 
(PPP) for 24 h. Western blot analysis of cleaved caspase 
3 revealed that IGF-IR inhibition induced apoptosis in 
both cell lines (Fig.  5a). We also observed a significant 
increase of cleaved caspase 3 when cells were stimulated 
with IGF-I or IGF-II in the presence of PPP, this effect 
being greater with IGF-II stimulation (Fig.  5a). After-
wards, a dose–response curve of thapsigargin, an inhibi-
tor of the endoplasmic reticulum (ER)  Ca2+-ATPase 
inducing ER stress [24], was performed in  IRLoxP+/+ and 
 IR−/− VSMCs. The expression of cleaved caspase 3 was 
found at a 100  nmol/L dose of thapsigargin in the two 
cell lines studied and this effect was significantly lower in 
 IR−/− VSMCs (Fig.  5b). Additionally, pretreatment with 
IGF-I, but not with IGF-II, reduced thapsigargin-induced 
apoptosis in  IRLoxP+/+ and  IR−/− VSMCs measured by 
Western blot of active caspase 3 (Fig.  5c). In this sense, 
we also checked that IGF-I increased the percentage of 
viable cells and prevented from early and late apoptosis 
in  IRLoxP+/+ and  IR−/− VSMCs (Additional file 5: Figure 
S5). These results suggest that IGF-I through IGF-IR has 
an antiapoptotic effect on VSMCs that may favor plaque 
stability by preventing the loss of those cells in athero-
sclerotic plaques.
Based on the reduced IRA/IRB ratio observed in com-
plicated human plaques and in advanced experimental 
atherosclerosis, we wondered whether IR isoforms could 
have a differential contribution to VSMCs apoptosis. 
For this purpose, we studied the apoptosis induced by 
thapsigargin in IRA and IRB VSMCs. Cells exclusively 
expressing IRB showed a significantly higher increase of 
Fig. 2 IGF‑IR and IGF‑IIR expression, and VSMCs content in human carotid atherosclerotic plaques. a Representative gels and quantifications of 
IGF‑IR and IGF‑IIR protein levels in supernatants from serial immunoprecipitations (IRB and IRA) of non‑complicated regions (n = 10) and their 
respective complicated plaques (n = 10). b Analysis of VSMCs content by Western blot against α‑SMA in non‑complicated regions (n = 10) and 
their respective complicated plaques (n = 10). ***p < 0.0005 vs. NCP. CP complicated region of atherosclerotic plaque, IP immunoprecipitation, NCP 
non‑complicated region
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cleaved caspase 3 as compared to IRA VSMCs (Fig. 6a). 
Finally, IGF-IR inhibition by PPP enhanced the thapsi-
gargin-induced apoptosis of IRB VSMCs in a significant 
way (Fig.  6b, c and Additional file  6: Figure S6). How-
ever, in  IRLoxP+/+ VSMCs, expressing both IR isoforms, 
PPP caused a lower increase of cleaved caspase 3 levels 
(Fig.  6b, c and Additional file  6: Figure S6). These data 
indicate that, in addition to IGF-IR inhibition, decreased 
IRA/IRB ratio may contribute to VSMCs apoptosis and 
thereby to plaque instability (Fig. 7). 
Discussion
In early stages of atherosclerosis, abnormal prolif-
eration and migration of VSMCs is a major contribu-
tor to atherogenesis. By contrast, VSMCs in advanced 
lesions are generally regarded as having atheroprotec-
tive plaque-stabilizing properties [3]. Indeed, clinical 
studies have reported that atherosclerotic plaques with 
a relative decrease of VSMCs and a thin fibrous cap, as 
well as increased inflammatory cells, were less stable and 
more prone to rupture [25, 26]. In this sense, it has been 
described that VSMCs present in human atherosclerotic 
lesions showed higher apoptosis than those derived from 
normal vessels [27].
The IR isoforms possess different functional features. 
Whereas IRB upregulation is associated with predomi-
nant metabolic insulin signaling, an increased expres-
sion of IRA is associated with decreased metabolic 
insulin signaling and increased IGF signaling, favoring 
cell growth, proliferation and survival [8]. We previously 
Fig. 3 IR, IGF‑IR and IGF‑IIR expression in aorta from the 24‑week‑old model of experimental atherosclerosis. Representative photomicrographs 
and quantifications of immunohistochemistry against IR (a), IGF‑IR (c) or IGF‑IIR (e) in aortic roots from 24‑week‑old Control,  ApoE−/− and BATIRKO; 
 ApoE−/− mice. qRT‑PCR analysis of IRA and IRB isoforms (b) or IGF‑IR (d) expression in aorta from 24‑week‑old Control,  ApoE−/− and BATIRKO; 
 ApoE−/− mice. *p < 0.05, **p < 0.005, ***p < 0.0005 vs. Control mice; †p < 0.05 vs.  ApoE−/− mice. C 24 weeks (n = 7); AE 24 weeks (n = 8); B;AE 24 
weeks (n = 7). AE  ApoE−/−, B;AE BATIRKO;  ApoE−/−, C control
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described that overexpression of IRA isoform favors 
VSMCs proliferation and migration contributing to 
atherosclerotic progression [13, 14]. However, to our 
knowledge, no data are available regarding the expres-
sion profile of IR isoforms in advanced atherosclerotic 
lesions and their role in VSMCs apoptosis. In the cur-
rent paper, we have shown a decreased IRA/IRB ratio in 
complicated regions of human atherosclerotic plaques. 
Since IRA isoform binds IGF-II with higher affinity than 
IRB [7], its overexpression may promote proathero-
genic effects of IGF-II in early stages of atherosclerotic 
process. Conversely, in more advanced stages, in which 
a local action of IGF-II prevents plaque instability by 
promoting the proliferation of intimal VSMCs [28], a 
reduced IRA/IRB ratio could favor the destabilization 
of atherosclerotic plaques. Although there were no sig-
nificant changes on IRS-1 association with IR isoforms, 
its serine phosphorylation was increased as well as Akt 
and p42/44 MAPK phosphorylation were diminished in 
complicated regions of human plaques. The phosphoryla-
tion of IRS-1 on serine residues is associated with insu-
lin resistance induced by cytokines such as TNF-α, since 
it inhibits IRS-1 tyrosine phosphorylation leading to 
impaired insulin signaling [29]. In addition, the increase 
of IRA/IGF-IR hybrid receptors in complicated regions 
might also be contributing to vascular insulin resistance 
Fig. 4 VSMCs content and apoptosis in atherosclerotic plaques from the 24‑week‑old experimental model. Representative photomicrographs and 
quantification of immunofluorescence against α‑SMA (a) and of immunohistochemistry against cleaved PARP (b) in aortic roots from 24‑week‑
old Control,  ApoE−/− and BATIRKO;  ApoE−/− mice. DAPI staining was performed to localize nuclei of cells presented in aortic roots (blue staining). 
***p < 0.0005 vs. Control mice; †††p < 0.0005 vs.  ApoE−/− mice. C 24 weeks (n = 7); AE 24 weeks (n = 8); B;AE 24 weeks (n = 7). AE  ApoE−/−, B;AE 
BATIRKO;  ApoE−/−, C control, DAPI 4′,6‑diamidino‑2‑phenylindole, PARP poly ADP ribose polymerase, α-SMA α‑smooth muscle actin
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since it has been previously described IRs organized as 
holoreceptors favor insulin signaling [30]. There is ample 
clinical evidence that insulin resistance increases the risk 
for cardiovascular diseases even in the absence of hyper-
glycemia. Insulin resistance syndromes can promote both 
atherogenesis and advanced plaque progression, and the 
mechanisms likely involve both systemic factors, particu-
larly dyslipidemia, hypertension, and a pro-inflammatory 
state, but also the effect of perturbed insulin signaling 
at the level of the intimal cells that participate in ath-
erosclerosis, including endothelial cells, VSMCs, and 
macrophages [31]. In this sense, atherosclerotic plaques 
from diabetic subjects had larger necrotic cores, greater 
infiltration of inflammatory cells and increased apoptotic 
VSMCs and macrophages than nondiabetic subjects [32].
We also observed a decreased expression of IGF-IR in 
complicated as compared to non-complicated regions of 
human carotid plaques. IGF-I through IGF-IR prevents 
apoptosis, and promotes extracellular matrix formation, 
proliferation and migration of VSMCs. Furthermore, it 
has been described that IGF-I was less potent in induc-
ing the survival of VSMCs from the endarterectomy 
specimens of symptomatic patients than those of asymp-
tomatic subjects [33]. In this context, a decreased expres-
sion of IGF-I and IGF-IR in advanced atherosclerotic 
plaques has been involved in VSMCs apoptosis leading 
to plaque instability and rupture [18–20]. By contrast, 
IGF-IIR was increased in complicated human carotid 
plaques. There are evidences showing that in addition to 
lysosomal degradation of IGF-II [9], IGF-IIR may trigger 
intracellular signaling cascades involved in cell behavior 
regulation [10, 11]. Deficiency of IGF-IIR in transgenic 
mice leads to ventricular hyperplasia in heart with an 
increased proliferation of fetal cardiomyocytes [34]. On 
the other hand, an increased cardiac expression of IGF-
II and IGF-IIR and cardiomyocyte apoptosis were found 
Fig. 5 Antiapoptotic effect of IGF‑IR on VSMCs. a Effect of IGF‑IR inhibition by PPP (1 µmol/L) on cleaved caspase 3 levels analyzed by Western blot 
in  IRLoxP+/+ and  IR−/− VSMCs stimulated with IGF‑I (10 nmol/L) or IGF‑II (10 nmol/L) for 24 h. b Dose–response effect of thapsigargin (0‑100 nmol/L, 
18 h) on cleaved caspase 3 levels in  IRLoxP+/+ and  IR−/− VSMCs. c Effect of IGF‑I or IGF‑I pretreatment (10 nmol/L, 1 h) in  IRLoxP+/+ and  IR−/− VSMCs 
treated with thapsigargin (100 nmol/L) for 18 h. Experiments were performed 4 or 5 times. *p < 0.05, **p < 0.005, ***p < 0.0005 vs. each control; 
†p < 0.05 vs.  IRLoxP+/+ VSMCs. PPP picropodophyllin
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in hypertensive rats with abdominal aorta ligation [35]. 
Other studies have supported the idea that IGF-II, act-
ing through IGF-IIR, may promote the death of cardiac 
myocytes [36–38]. According to that data, the upregula-
tion of IGF-IIR in atherosclerotic lesions could contrib-
ute to plaque instability by two potential mechanisms: 
reduced IGF-II bioavailability and thereby less effect on 
cell survival, or increased apoptosis of plaque-resident 
cells. Several studies have demonstrated the presence of 
apoptosis in human atherosclerotic plaques as the lead-
ing cause of loss of VSMCs [27, 39, 40]. Thus, unstable 
plaques from coronary atherectomy contained less apop-
totic VSMCs and a reduced total cell number than stable 
plaques [41]. Consistently, we have described a decrease 
of VSMCs content in complicated human atherosclerotic 
plaques in relation to non-complicated regions. However, 
one of the limitations of this study is the small number 
of patients included, since it is difficult to obtain samples 
of the complicated and non-complicated regions of ath-
erosclerotic plaques from the same patient. Therefore, in 
order to validate our results from human atherosclerotic 
plaques, additional studies including a greater number of 
patients need to be performed.
To assess whether the results obtained from human 
atherosclerotic plaques could be found in experimen-
tal atherosclerotic lesions, we used 24-week-old and 
15-month-old BATIRKO;  ApoE−/− mice that showed 
more advanced atherosclerotic plaques than  ApoE−/− 
mice. Nevertheless, although hyperlipidemic genetically 
manipulated models such as  ApoE−/− mice developed 
Fig. 6 Differential contribution of IR isoforms to VSMCs apoptosis. a Effect of thapsigargin (100 nmol/L, 18 h) on cleaved caspase 3 levels analyzed 
by Western blot in IRA and IRB VSMCs. b Effect of IGF‑IR inhibition by PPP (1 µmol/L) on cleaved caspase 3 levels in IRB and  IRLoxP+/+ VSMCs treated 
with thapsigargin (100 nmol/L) for 18 h. Experiments were performed 4 times. *p < 0.05, **p < 0.005, ***p < 0.0005 vs. each control; ††p < 0.005 vs. 
IRA VSMCs; §p < 0.05 vs. each thapsigargin; Δp < 0.05 vs.  IRLoxP+/+ VSMCs. PPP: picropodophyllin. c % of early apoptotic cells in G2. These cells were 
stained positively for Annexin V‑FITC and negatively for propidium iodide. *p < 0.05 vs. each control; ***p < 0.001 vs. each control; †p < 0.05 vs. each 
thapsigargin; †††p < 0.001 vs. each thapsigargin; ΔΔΔp < 0.001 vs. each point of  IRLoxP+/+ VSMCs
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the entire spectrum of lesions similar to those of humans, 
their major limitation is the infrequency of plaque rup-
ture and thrombosis, two common complications of 
human atherosclerosis [42]. Therefore, some, but not 
all, of the findings from complicated regions of human 
plaques were also observed in atherosclerosis plaques 
from BATIRKO;  ApoE−/− mice: decreased IRA/IRB ratio, 
increasing trend of IGF-IIR and reduced VSMC content 
with an increase of apoptotic cells. However, IGF-IR 
expression was increased in total area of aortic roots, but 
decreased in the media, in both  ApoE−/− and BATIRKO; 
 ApoE−/− mice vs. Control mice.
Our in  vitro results indicate an antiapoptotic role 
of IGF-IR in VSMCs. The inhibition of IGF-IR by PPP 
induced apoptosis in  IRLoxP+/+ and  IR−/− VSMCs. We 
previously observed that the lack of IR in VSMCs led to 
an increased expression of IGF-IR [14], and this seems 
to be responsible for the lower thapsigargin-induced 
apoptosis that we found in  IR−/− VSMCs as compared 
to  IRLoxP+/+ VSMCs. Moreover, IGF-I, but not IGF-II, 
exerts a protective effect on the thapsigargin-induced 
apoptosis of VSMCs. Consistently, VSMCs from human 
atherosclerotic plaques showed an intrinsic sensitivity 
to apoptosis caused in part by defective expression of 
IGF-IR, impaired IGF-I-mediated survival signaling and 
increased IGFBP secretion [19]. Oxidized LDL uptake 
has been proposed as a mechanism triggering apoptosis 
in VSMCs mediated by downregulation of IGF-IR [43]. 
Thus, overexpression of IGF-IR by using an adenovirus 
completely abrogated this effect on human VSMCs [44]. 
By contrast, IGF-II not only does not prevent VSMCs 
apoptosis, but also appears to enhance thapsigargin-
induced apoptosis in VSMCs lacking IR. This effect could 
be explained by IGF-II binding to IGF-IIR that, as men-
tioned above, has been reported to promote apoptosis 
in cardiomyocytes [33–36]. Finally, we found a differ-
ential contribution of IR isoforms to VSMCs apoptosis, 
since cells exclusively expressing IRB were more prone to 
thapsigargin-induced apoptosis than IRA or  IRLoxP+/+ 
VSMCs.
Overall, the data in this study advance our understand-
ing of the pathophysiology of human carotid athero-
thrombosis and the potential role of IR isoforms and 
IGFs receptors in the stability of atherosclerotic plaques. 
Thus, our findings suggest that manipulation of the IGF-I 
autocrine/paracrine pathway may be a useful strategy to 
limit the loss of VSMCs that contribute to atherosclerotic 
plaque destabilization.
Conclusions
In conclusion, our results show for the first time a 
decreased IRA/IRB ratio and increased IGF-IIR expres-
sion as well as reduced IGF-IR expression in complicated 
versus non-complicated regions of human atheroscle-
rotic plaques  (Fig.  7). These events may contribute to an 
increased apoptosis and subsequent loss of VSMCs, pro-
moting plaque instability and leading to a higher risk of 
plaque rupture with the outcome of vascular complications 
aggravation.
Fig. 7 Proposed scheme of an advanced atherosclerotic plaque showing the expression profiles of IR isoforms (IRA and IRB), IGF‑IR and IGF‑IIR. We 
found a decreased IRA/IRB ratio, increased IGF‑IIR expression, and reduced IGF‑IR expression, as well as lower VSMCs content in complicated versus 
non‑complicated regions of human carotid plaques. In experimental models developing advanced atherosclerotic plaques, we also observed a 
reduced IRA/IRB ratio, a decrease of VSMCs content and an increase of apoptotic cell number. Finally, our in vitro results show that a decrease of IGF‑
IR expression and the presence of IRB as the predominant IR isoform increase the apoptosis of VSMCs. Therefore, this scenario could contribute to a 
loss of VSMCs, promoting plaque instability and leading to a higher risk of plaque rupture with the outcome of vascular complications aggravation. 
ECs endothelial cells, VSMCs vascular smooth muscle cells
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Additional files
Additional file 1: Figure S1. Histological analysis of human carotid 
atherosclerotic plaques. Masson’s trichrome stain of representative non‑
complicated and complicated plaques of human carotid atherosclerosis. 
Different regions of the plaque are shown: M: media; F: fibrous region; A: 
atheroma; S: shoulder.
Additional file 2: Figure S2. Differential insulin signaling in complicated 
and non‑complicated regions from atherosclerotic plaques. Western blot 
analysis of phosphorylation of Akt (A) and p42/44 MAPK (B) protein levels 
in supernatants from serial immunoprecipitations (IRB and IRA) of non‑
complicated regions (n = 10) and their respective complicated regions 
(n = 10). CP: complicated region of atherosclerotic plaque; IP: immuno‑
precipitation; NCP: non‑complicated region. *p < 0.05 vs. NCP; **p < 0.001 
vs. NCP.
Additional file 3: Figure S3. IR and IGF‑IR expression in aorta from the 
15‑month‑old model of experimental atherosclerosis. Representative 
photomicrographs and quantifications of immunohistochemistry against 
IR (A) or IGF‑IR (B) in aortic roots from 15‑month‑old Control,  ApoE−/− 
and BATIRKO;  ApoE−/− mice. **p < 0.005, ***p < 0.0005 vs. Control mice; 
††p < 0.005 vs.  ApoE−/− mice. C 15 m (n = 7); AE 15 m (n = 6); B; AE 15 m 
(n = 6). AE:  ApoE−/−, B;AE: BATIRKO;  ApoE−/−; C: Control.
Additional file 4: Figure S4. VSMC content and apoptosis in athero‑
sclerotic plaques from the 15‑month‑old experimental model. Repre‑
sentative photomicrographs and quantification of immunofluorescence 
against α‑SMA (A) and of immunohistochemistry against cleaved PARP 
(B) in aortic roots from 15‑month‑old Control,  ApoE−/− and BATIRKO; 
 ApoE−/− mice. DAPI staining was performed to localize nuclei of cells 
presented in aortic roots (blue staining). *p < 0.05, ***p < 0.0005 vs. 
Control mice; †p < 0.05 vs.  ApoE−/− mice. C 15 m (n = 7); AE 15 m (n = 6); 
B;AE 15 m (n = 6). AE:  ApoE−/−, B;AE: BATIRKO;  ApoE−/−; C: Control; DAPI: 
4′,6‑diamidino‑2‑phenylindole; PARP: poly ADP ribose polymerase; α‑SMA: 
α‑smooth muscle actin.
Additional file 5: Figure S5. Antiapoptotic effect of IGF‑IR and IGF‑I on 
 IRLoxP+/+ and  IR−/− VSMCs. Analysis of dead cells by Annexin V‑FITC and 
propidium iodide assays. (A) Representative images of % necrotic cells 
(UL), % dead cells (UR), % viable cells (LL) and % early apoptotic cells (LR) 
in G1 Gate. FL1H (x‑axis, Annexin V FITC); FL3H (y‑axis, propidium iodide). 
Graphics of % of viable, % of apoptotic cells (B), % of necrotic cells, % of 
dead cells and % of early apoptotic cells (C). *p < 0.05 vs. each Control; 
**p < 0.001 vs. each Control; **p < 0.0001 vs. each control; †p < 0.05 vs. 
each thapsigargin; †††p < 0.0001 vs. each thapsigargin.
Additional file 6: Figure S6. Differential apoptotic effects of thapsigar‑
gin and IGF‑IR inhibitor on  IRLoxP+/+ and IRB VSMCs. Analysis of dead 
cells by Annexin V‑FITC and propidium iodide assays. (A) Representative 
images of % necrotic cells (UL), % dead cells (UR), % viable cells (LL) and 
% early apoptotic cells (LR) in G1 Gate. FL1H (x‑axis, Annexin V FITC); 
FL3H (y‑axis, propidium iodide). Graphics of % of viable, % of apoptotic 
cells (B), % of necrotic cells, % of dead cells and % of early apoptotic cells 
(C). *p < 0.05 vs. each control; **p < 0.001 vs. each control; **p < 0.0001 
vs. each control; †p < 0.05 vs. each thapsigargin; †††p < 0.0001 vs. each 
thapsigargin.
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